Symbols / MGRX $0.38 +13.61% Mangoceuticals, Inc.

Healthcare • Health Information Services • United States • NCM
MGRX Chart
About

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. The company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Health Information Servi Market Cap 6.25M
Enterprise Value 4.56M Income -21.82M Sales 456.02K
Book/sh 1.13 Cash/sh 0.09 Dividend Yield —
Payout 0.00% Employees — IPO —
P/E — Forward P/E — PEG —
P/S 13.72 P/B 0.34 P/C —
EV/EBITDA -0.29 EV/Sales 9.99 Quick Ratio 1.67
Current Ratio 1.74 Debt/Eq 2.02 LT Debt/Eq —
EPS (ttm) -2.17 EPS next Y — EPS Growth —
Revenue Growth -10.30% Earnings — ROA -69.91%
ROE -141.66% ROIC — Gross Margin 54.91%
Oper. Margin -15.76% Profit Margin 0.00% Shs Outstand 16.29M
Shs Float 11.15M Short Float 8.45% Short Ratio 0.06
Short Interest — 52W High 2.88 52W Low 0.16
Beta — Avg Volume 12.90M Volume 1.04M
Target Price — Recom None Prev Close $0.34
Price $0.38 Change 13.61%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.38
Latest analyst target
3. DCF / Fair value
$0.87
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.38
Low
—
High
—
Mean
—
News
RSS: Latest MGRX news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-12-15 JOHNSTON EUGENE M Chief Financial Officer — 3,333 $1.17 $3,884
2025-12-09 JOHNSTON EUGENE M Chief Financial Officer — 5,000 $1.20 $5,975
2025-12-05 JOHNSTON EUGENE M Chief Financial Officer — 10,000 $1.13 $11,280
2025-11-19 HAMILTON ALEX P Director — 125,000 $1.22 $152,875
2025-09-09 JOHNSTON EUGENE M Chief Financial Officer — 100,000 $0.00 $0
2025-09-09 COHEN JACOB D. Chief Executive Officer — 500,000 $0.00 $0
2025-09-09 MYERS KENNY Director — 100,000 $0.00 $0
2025-09-09 D'ALESSIO LORRAINE PAMELA Director — 100,000 $0.00 $0
2025-09-09 HAMILTON ALEX P Director — 100,000 $0.00 $0
2025-06-05 COHEN JACOB D. Chief Executive Officer — 200,000 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.46
-25.96%
0.62
-15.81%
0.73
+8083.16%
0.01
Operating Revenue
0.46
-25.96%
0.62
-15.81%
0.73
+8083.16%
0.01
Cost Of Revenue
0.21
-12.83%
0.24
-21.36%
0.30
+7236.56%
0.00
Reconciled Cost Of Revenue
0.21
-9.00%
0.23
+2.66%
0.22
+5283.32%
0.00
Gross Profit
0.25
-34.10%
0.38
-11.94%
0.43
+8796.93%
0.00
Operating Expense
19.41
+113.87%
9.07
-5.98%
9.65
+383.38%
2.00
Selling General And Administration
16.72
+111.71%
7.90
-7.62%
8.55
+328.26%
2.00
Selling And Marketing Expense
0.82
-44.35%
1.48
-29.50%
2.10
+494.43%
0.35
General And Administrative Expense
15.90
+147.66%
6.42
-0.51%
6.45
+292.59%
1.64
Salaries And Wages
12.14
+255.14%
3.42
+9.13%
3.13
0.00
Other Gand A
3.76
+25.19%
3.00
-9.61%
3.32
+101.96%
1.64
Other Operating Expenses
1.56
+244.07%
0.45
-58.77%
1.10
—
Total Expenses
19.61
+110.66%
9.31
-6.44%
9.95
+397.39%
2.00
Operating Income
-19.15
-120.34%
-8.69
+5.70%
-9.22
-362.89%
-1.99
Total Operating Income As Reported
-18.03
-126.20%
-7.97
+13.53%
-9.22
-362.89%
-1.99
EBITDA
-18.82
-136.32%
-7.96
+12.82%
-9.13
-359.45%
-1.99
Normalized EBITDA
-17.43
-118.92%
-7.96
+12.82%
-9.13
-359.45%
-1.99
Reconciled Depreciation
1.72
+135.72%
0.73
+815.85%
0.08
+1967.51%
0.00
EBIT
-20.54
-136.27%
-8.69
+5.63%
-9.21
-362.57%
-1.99
Total Unusual Items
-1.38
0.00
—
—
Total Unusual Items Excluding Goodwill
-1.38
0.00
—
—
Special Income Charges
-1.38
0.00
—
—
Other Special Charges
0.15
—
—
—
Impairment Of Capital Assets
1.24
—
—
—
Net Income
-20.64
-137.11%
-8.71
+5.50%
-9.21
-361.07%
-2.00
Pretax Income
-20.64
-137.08%
-8.71
+5.48%
-9.21
-361.07%
-2.00
Net Non Operating Interest Income Expense
-0.10
-655.57%
-0.01
0.00
+100.00%
-0.01
Interest Expense Non Operating
0.10
+655.57%
0.01
0.00
-100.00%
0.01
Net Interest Income
-0.10
-655.57%
-0.01
0.00
+100.00%
-0.01
Interest Expense
0.10
+655.57%
0.01
0.00
-100.00%
0.01
Other Income Expense
-1.38
—
0.01
—
Other Non Operating Income Expenses
—
—
0.01
—
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-20.64
-137.08%
-8.71
+5.48%
-9.21
-361.07%
-2.00
Net Income From Continuing Operation Net Minority Interest
-20.64
-137.11%
-8.71
+5.50%
-9.21
-361.07%
-2.00
Net Income From Continuing And Discontinued Operation
-20.64
-137.11%
-8.71
+5.50%
-9.21
-361.07%
-2.00
Net Income Continuous Operations
-20.64
-137.08%
-8.71
+5.48%
-9.21
-361.07%
-2.00
Minority Interests
0.00
-57.35%
0.00
0.00
—
Normalized Income
-19.26
-121.20%
-8.71
+5.50%
-9.21
-361.07%
-2.00
Net Income Common Stockholders
-21.82
-129.47%
-9.51
-3.21%
-9.21
-361.07%
-2.00
Diluted EPS
—
-4.80
+44.06%
-8.58
-338.44%
-1.96
Basic EPS
—
-4.80
+44.06%
-8.58
-338.44%
-1.96
Basic Average Shares
—
1.98
+84.23%
1.07
+5.21%
1.02
Diluted Average Shares
—
1.98
+84.23%
1.07
+5.21%
1.02
Diluted NI Availto Com Stockholders
-21.82
-129.47%
-9.51
-3.21%
-9.21
-361.07%
-2.00
Amortization
1.12
+55.59%
0.72
0.00
—
Amortization Of Intangibles Income Statement
1.12
+55.59%
0.72
0.00
—
Depreciation Amortization Depletion Income Statement
1.12
+55.59%
0.72
0.00
—
Depreciation And Amortization In Income Statement
1.12
+55.59%
0.72
0.00
—
Preferred Stock Dividends
1.18
+46.61%
0.80
—
—
Line Item Trend 2023-12-31
Total Assets
1.05
Current Assets
0.84
Cash Cash Equivalents And Short Term Investments
0.74
Cash And Cash Equivalents
0.74
Cash Financial
0.74
Receivables
—
Inventory
0.02
Finished Goods
0.02
Prepaid Assets
0.08
Total Non Current Assets
0.22
Net PPE
0.22
Gross PPE
0.24
Accumulated Depreciation
-0.03
Machinery Furniture Equipment
0.01
Other Properties
0.24
Goodwill And Other Intangible Assets
0.00
Other Intangible Assets
—
Non Current Prepaid Assets
0.02
Total Liabilities Net Minority Interest
0.28
Current Liabilities
0.21
Payables And Accrued Expenses
0.15
Payables
0.15
Accounts Payable
0.14
Other Payable
—
Total Tax Payable
0.01
Current Debt And Capital Lease Obligation
0.06
Current Debt
—
Current Capital Lease Obligation
0.06
Total Non Current Liabilities Net Minority Interest
0.06
Long Term Debt And Capital Lease Obligation
0.06
Long Term Capital Lease Obligation
0.06
Stockholders Equity
0.77
Common Stock Equity
0.77
Capital Stock
0.00
Common Stock
0.00
Preferred Stock
0.00
Share Issued
1.43
Ordinary Shares Number
1.43
Treasury Shares Number
0.00
Additional Paid In Capital
12.00
Retained Earnings
-11.23
Gains Losses Not Affecting Retained Earnings
0.00
Minority Interest
0.00
Other Equity Adjustments
—
Total Equity Gross Minority Interest
0.77
Total Capitalization
0.77
Working Capital
0.62
Invested Capital
0.77
Total Debt
0.13
Net Debt
—
Capital Lease Obligations
0.13
Net Tangible Assets
0.77
Tangible Book Value
0.77
Current Notes Payable
0.00
Duefrom Related Parties Current
—
Other Equity Interest
—
Preferred Stock Equity
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-5.85
-20.28%
-4.86
+30.49%
-7.00
-419.66%
-1.35
Cash Flow From Continuing Operating Activities
-5.85
-20.28%
-4.86
+30.49%
-7.00
-419.66%
-1.35
Net Income From Continuing Operations
-20.64
-137.08%
-8.71
+5.48%
-9.21
-361.07%
-2.00
Depreciation Amortization Depletion
1.72
+135.72%
0.73
+815.85%
0.08
+1967.51%
0.00
Depreciation
0.00
-89.81%
0.01
-60.08%
0.02
+544.29%
0.00
Amortization Cash Flow
1.72
+138.82%
0.72
+1212.38%
0.05
—
Depreciation And Amortization
1.72
+135.72%
0.73
+815.85%
0.08
+1967.51%
0.00
Amortization Of Intangibles
1.72
+138.82%
0.72
+1212.38%
0.05
—
Other Non Cash Items
10.79
+397.93%
2.17
+42.11%
1.52
+178.88%
0.55
Stock Based Compensation
1.17
+369.79%
0.25
-60.18%
0.62
+166.76%
0.23
Asset Impairment Charge
1.24
+6602.03%
0.02
0.00
—
Operating Gains Losses
0.15
+688.67%
0.02
—
-0.15
Gain Loss On Investment Securities
—
—
—
-0.15
Change In Working Capital
-0.27
-140.81%
0.66
+5003.67%
-0.01
-171.37%
0.02
Change In Receivables
-0.02
0.00
-100.00%
0.05
+131.55%
-0.17
Change In Inventory
—
0.00
+100.00%
-0.02
0.00
Change In Prepaid Assets
-0.02
-139.54%
0.06
+223.87%
-0.05
-71.53%
-0.03
Change In Payables And Accrued Expense
0.07
-89.72%
0.63
+470.45%
0.11
+204.92%
0.04
Change In Accrued Expense
0.00
+100.00%
-0.06
—
—
Change In Payable
0.07
-90.66%
0.70
+527.87%
0.11
+204.92%
0.04
Change In Account Payable
0.06
-92.01%
0.70
+550.61%
0.11
+218.01%
0.03
Change In Other Current Liabilities
-0.29
-764.43%
-0.03
+40.78%
-0.06
-130.60%
0.19
Investing Cash Flow
0.00
-100.00%
0.07
+1947.12%
-0.00
+91.84%
-0.04
Cash Flow From Continuing Investing Activities
0.00
-100.00%
0.07
+1947.12%
-0.00
+91.84%
-0.04
Net PPE Purchase And Sale
—
0.00
+100.00%
-0.00
+91.84%
-0.04
Purchase Of PPE
—
0.00
+100.00%
-0.00
+91.84%
-0.04
Capital Expenditure
—
—
-0.00
+91.84%
-0.04
Net Other Investing Changes
—
0.07
—
—
Financing Cash Flow
7.27
+76.12%
4.13
-41.50%
7.06
+244.26%
2.05
Cash Flow From Continuing Financing Activities
7.27
+76.12%
4.13
-41.50%
7.06
+244.26%
2.05
Net Issuance Payments Of Debt
0.47
+212.33%
0.15
+189.57%
-0.17
-435.39%
0.05
Issuance Of Debt
0.68
+350.00%
0.15
0.00
-100.00%
0.07
Repayment Of Debt
-0.21
0.00
+100.00%
-0.17
-567.97%
-0.03
Long Term Debt Payments
-0.21
0.00
—
—
Net Long Term Debt Issuance
-0.21
0.00
—
—
Short Term Debt Issuance
0.68
+350.00%
0.15
0.00
-100.00%
0.07
Short Term Debt Payments
—
0.00
+100.00%
-0.17
-567.97%
-0.03
Net Short Term Debt Issuance
0.68
+350.00%
0.15
+189.57%
-0.17
-435.39%
0.05
Net Common Stock Issuance
4.63
+248.22%
1.33
-78.58%
6.20
+210.00%
2.00
Proceeds From Stock Option Exercised
0.93
0.00
-100.00%
1.02
0.00
Net Other Financing Charges
1.15
—
—
—
Changes In Cash
1.42
+311.87%
-0.67
-1294.22%
0.06
-91.50%
0.66
Effect Of Exchange Rate Changes
0.01
+171.97%
-0.01
0.00
—
Beginning Cash Position
0.06
-92.06%
0.74
+8.22%
0.68
+2928.20%
0.02
End Cash Position
1.49
+2434.12%
0.06
-92.06%
0.74
+8.22%
0.68
Free Cash Flow
-5.85
-20.28%
-4.86
+30.53%
-7.00
-403.80%
-1.39
Interest Paid Supplemental Data
0.00
0.00
0.00
0.00
Income Tax Paid Supplemental Data
0.00
0.00
0.00
0.00
Change In Income Tax Payable
0.01
0.00
-100.00%
0.00
+42.73%
0.00
Change In Tax Payable
0.01
0.00
-100.00%
0.00
+42.73%
0.00
Common Stock Issuance
4.63
+248.22%
1.33
-78.58%
6.20
+210.00%
2.00
Issuance Of Capital Stock
4.73
+18.78%
3.98
-35.83%
6.20
+210.00%
2.00
Net Preferred Stock Issuance
0.10
-96.23%
2.65
0.00
—
Preferred Stock Issuance
0.10
-96.23%
2.65
0.00
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category